Late and booster anti-SARS-CoV-2 humoral responses in nonresponder vaccinated patients with rheumatic diseases receiving mycophenolate or rituximab: comment on the article by XXX et al.

Autor:	Bakasis AD; Department of Pathophysiology and School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; Institute for Autoimmune Systemic and Neurologic Diseases, Athens, Greece., Goules AV; Department of Pathophysiology and School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; Institute for Autoimmune Systemic and Neurologic Diseases, Athens, Greece., Vlachoyiannopoulos PG; Department of Pathophysiology and School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; Institute for Autoimmune Systemic and Neurologic Diseases, Athens, Greece., Bitzogli K; Institute for Autoimmune Systemic and Neurologic Diseases, Athens, Greece., Tzioufas AG; Department of Pathophysiology and School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; Institute for Autoimmune Systemic and Neurologic Diseases, Athens, Greece.
Jazyk:	angličtina
Zdroj:	ACR open rheumatology [ACR Open Rheumatol] 2022 Aug; Vol. 4 (8), pp. 645-646. Date of Electronic Publication: 2022 May 19.
DOI:	10.1002/acr2.11446
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text